Tuberculosis - Clinical Value of Initial Host Molecular Signalling and Molecular Fingerprinting
Mycobacterium tuberculosis (Mtb) is principally a pulmonary pathogen infecting one-third of the world's population and causing two million deaths annually. The only approved tuberculosis vaccine today is the Mycobacterium bovis bacilli Calmette-Guérin (BCG). BCG vaccine is used as a benchmark to compare the immunogenicity of new vaccines, but not much is known about its mechanisms to induce protec
